Clinical trials
Phase 2 Pituitary ACTH Hypersecretion trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Corcept Therapeutics | 2 |
| Cedars-Sinai Medical Center | 1 |
| H. Lundbeck A/S | 1 |
| Huashan Hospital | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Sparrow Pharmaceuticals | 1 |
| University of California, Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pituitary ACTH Hypersecretion | 12 |
| ACTH Syndrome, Ectopic | 3 |
| Cushing Syndrome | 3 |
| Adrenal Cortex Neoplasms | 2 |
| Adrenocortical Carcinoma | 2 |
| Adrenocortical Hyperfunction | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertension | 2 |
| Pituitary Diseases | 1 |
| Pituitary Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.